Literature DB >> 15979486

Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.

C M D Silva1, C Costi, C Costa, C Michelon, R Oravec, A B Ramos, C Niel, M L Rossetti.   

Abstract

OBJECTIVE: The aim of this study was to determine the rate of occult hepatitis B virus (HBV) infection among blood donors living in a geographic region of low (5.6%) anti-HBc prevalence. SUBJECTS AND METHODS: Sera from 150 candidate blood donors whose blood was rejected due to total anti-HBc reactivity (despite absence of HBsAg) were tested for anti-HBs and IgM anti-HBc antibodies, as well as for HBeAg/anti-HBe. Serum HBV DNA was sought by using a PCR assay able to amplify part of the surface gene. Viral load was measured in the PCR positive samples.
RESULTS: The pattern 'anti-HBc alone' (without HBsAg and anti-HBs antibodies) was found in 64 (42.7%) subjects. IgM anti-HBc and anti-HBe antibodies were detected in 2 (1.3%) and 80 (53.3%) samples, respectively. No sample was HBeAg-reactive. HBV DNA was repeatedly found in five (3.3%) samples, three of which were anti-HBs positive and two anti-HBs negative. All five HBV DNA positive samples showed a low viral load (<1000copies/ml).
CONCLUSIONS: The data indicated a low rate of occult infection among anti-HBc positive, HBsAg negative blood donors living in a region of low prevalence of infection. Viral load was very low in all HBV infected subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15979486     DOI: 10.1016/j.jinf.2004.07.007

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Visual detection of multiple viral amplicons by dipstick assay: its application in screening of blood donors a welcome tool for the limited resource settings.

Authors:  B R Panhotra; Z U Hassan; C S Joshi; A Bahrani
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen.

Authors:  Assem M El-Sherif; Mohamed A Abou-Shady; Mohsen A Al-Hiatmy; Ashraf M Al-Bahrawy; Elham A Motawea
Journal:  Hepatol Int       Date:  2007-09-15       Impact factor: 6.047

Review 3.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy.

Authors:  M N dos S Moresco; H de A Virgolino; M P E de Morais; I da Motta-Passos; M S Gomes-Gouvêa; L M S de Assis; K R de L Aguiar; S C F Lombardi; A Malheiro; N de P Cavalheiro; J E Levi; K L Torres
Journal:  Vox Sang       Date:  2014-02-21       Impact factor: 2.144

5.  Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities.

Authors:  Mohammad Kazemi Arababadi; Gholamhossein Hassanshahi; Ali Akbar Pourfathollah; Ebrahim Rezazadeh Zarandi; Derek Kennedy
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

6.  Prevention of post-transfusion hepatitis by screening of antibody to hepatitis B core antigen in healthy blood donors.

Authors:  S Shastry; S S Bhat
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-18       Impact factor: 2.576

7.  Hepatitis B Virus Genotype D Isolates Circulating in Chapecó, Southern Brazil, Originate from Italy.

Authors:  Carolina Souza Gusatti; Cintia Costi; Maria Laura Halon; Tarciana Grandi; Arlete Ferrari Rech Medeiros; Cláudia Maria Dornelles Silva; Selma Andrade Gomes; Marcia Susana Nunes Silva; Christian Niel; Maria Lucia Rosa Rossetti
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

8.  T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc.

Authors:  Patricia Araujo; Roger Y Dodd; Flavia Latinni; Renata Souza; Ricardo Diaz; Jose Augusto Barreto
Journal:  J Biomark       Date:  2013-12-03

9.  Comparison of epidemiological methods for estimation of hepatitis B incidence and residual risk for blood donors in southern Brazil.

Authors:  Emil Kupek; Andrea Petry
Journal:  J Transfus       Date:  2011-05-10

10.  The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons.

Authors:  Kiana Shirani; Zary Nokhodian; Nazila Kassaian; Peyman Adibi; Alireza Emami Naeini; Behrooz Ataei
Journal:  Adv Biomed Res       Date:  2015-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.